SARS-CoV-2 epitopes inform future vaccination strategies
All currently approved COVID-19 vaccines utilize the spike protein as their immunogen. SARS-CoV-2 variants of concern (VOCs) contain mutations in the spike protein, enabling them to escape infection- and vaccination-induced immune responses to cause reinfection. New vaccines are hence being research...
Main Authors: | Areez Shafqat, Mohamed H. Omer, Omar Ahmad, Mahnoor Niaz, Humzah S. Abdulkader, Shameel Shafqat, Ali Hassan Mushtaq, Abdullah Shaik, Ahmed N. Elshaer, Junaid Kashir, Khaled Alkattan, Ahmed Yaqinuddin |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.1041185/full |
Similar Items
-
Effect of SARS-CoV-2 Mutations on the Efficacy of Antibody Therapy and Response to Vaccines
by: Ahmed Yaqinuddin, et al.
Published: (2021-08-01) -
Understanding COVID-19 Vaccines Today: Are T-cells Key Players?
by: Areez Shafqat, et al.
Published: (2022-06-01) -
A Supercluster of Neutralizing Epitopes at the Interface of Ricin’s Enzymatic (RTA) and Binding (RTB) Subunits
by: Amanda Y. Poon, et al.
Published: (2017-11-01) -
Bispecific Antibodies in Hematological Malignancies: A Scoping Review
by: Mohamed H. Omer, et al.
Published: (2023-09-01) -
Research progress on neutralizing epitopes and antibodies for the Rabies virus
by: Chenjuan Shi, et al.
Published: (2022-12-01)